Savient was once a high flying biotech, and many articles were published talking about what a great investment SVNT stock was. Looking at a stock chart, Savient looks like a falling knife, which may be scaring off even the most seasoned investors.
Seeking Alpha · BySteven Breazzano · 9/22/2011
It would be great if biotech stocks - small cap biotechs in particular - reflected some sort of underlying value. Problem is, with young biotech names, there isn't always a 'value' to determine. That doesn't mean these stocks can't rise, however.
Smallcap Network · ByBryan Murphy · 8/21/2012
Savient Pharmaceuticals, Inc. SVNT is currently up (+80%) from its recent 52-week low, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. monitors and scans …
Market Watch · 10/17/2013
More from Bing News
Savient Pharmaceuticals Inc. (NASDAQ: SVNT ) options action suggests at least one investor expects the stock to drop during the next month. A hefty number of near-term puts crossed the tape out of the gate and the majority of the action appears to be …
NASDAQ · 7/16/2010
Investors in Savient Pharmaceuticals Inc (SVNT) saw new options begin trading today, for the July expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SVNT options chain for the new July contracts and identified the ...
The Street · 5/20/2013
Shares of Savient Pharma (Nasdaq: SVNT) are moving lower in the pre-market trading session as an analyst at Cowen & Co. has downgraded the stock from Outperform to Neutral. The stock last traded at $21.96, down about 0.9% from yesterday's closing …
StreetInsider · 10/5/2010
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) is among the top mid day mover and surged 4.81% at $14.81 on huge volume of 1.57 million shares till now after Savient Pharmaceuticals, Inc. announced today the closing of itspreviously announced …
TransWorldNews · 10/16/2009
Shares are lower by about 6.4 percent. Cisco Systems ( CSCO) was upgraded by Deutsche Bank from a hold to buy with a $22.00 price target on the stock. Earnings, revenue and profit margins all beat forecasts. Shares are trading higher by over 6.7 percent.
Forbes · 11/10/2011
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) already had problems before a fund called Tang Capital accused it of being insolvent this week. Over the last year this stock has fallen down steadily just like its stock chart was a staircase… Down ...
24/7 Wall ST · 5/2/2012
Savient Pharmaceuticals (SVNT): The stock is slashed to Market ... WSM): Bank of America-Merrill Lynch lowers the owner of Pottery Barn to Neutral from Buy. A strong recent run in the stock, now up 52.24% in the past year, has left it due a breather.
Minyanville · ByJustin Sharon · 5/17/2013